Aristo Bio-Tech and Lifescience Limited (NSE:ARISTO)
India · Delayed Price · Currency is INR 109.25
0.00 (0.00%)
At close: Jul 22, 2026
NSE:ARISTO Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 3,637 | 3,637 | 3,181 | 2,451 | 2,179 | 1,658 |
Revenue Growth | 0.92% | 14.34% | 29.75% | 12.53% | 31.43% | -0.87% |
Gross Profit Gross Profit Growth | 329.45 | 329.45 | 222.43 | 186.49 | 218.55 | 185.63 |
Operating Income Operating Income Growth | 131.27 | 131.27 | 68.82 | 69.94 | 72.58 | 41.34 |
Net Income Net Income Growth | 71.83 | 71.83 | 40.63 | 38.96 | 35.62 | 14.34 |
Earnings Per Share EPS Growth | 10.55 | 10.55 | 5.97 | 5.72 | 6.72 | 2.87 |
EPS Growth | 95.30% | 76.77% | 4.34% | -14.88% | 134.14% | 33.27% |
| Fiscal Year | FY 2025 | FY 2024 |
|---|---|---|
| Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 |
Export Export Growth | 48.95 | 79.31 |
India India Growth | 3,094 | 2,358 |
Unallocated Unallocated Growth | 37.94 | 14.26 |
Total Total Growth | 3,181 | 2,451 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 26.27 | 26.27 | 42.97 | 54.13 | 38.03 | 26 |
Total Debt Total Debt Growth | 353.99 | 353.99 | 218.54 | 208.76 | 224.9 | 254.84 |
Net Cash (Debt) Net Cash Growth | -327.72 | -327.72 | -175.57 | -154.63 | -186.87 | -228.84 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -48.14 | -48.14 | -25.79 | -22.71 | -35.25 | -45.81 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 84.44 | 84.44 | 100.17 | 76 | -27.84 | 67.78 |
Capital Expenditures CapEx Growth | -29.61 | -29.61 | -51.07 | -65.55 | -40.61 | -32.49 |
Free Cash Flow Free Cash Flow Growth | 54.83 | 54.83 | 49.1 | 10.45 | -68.44 | 35.29 |
Free Cash Flow Growth | 24.28% | 11.67% | 369.65% | - | - | 1097.18% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 9.06% | 9.06% | 6.99% | 7.61% | 10.03% | 11.20% |
Operating Margin | 3.61% | 3.61% | 2.16% | 2.85% | 3.33% | 2.49% |
Pretax Margin | 2.67% | 2.67% | 1.72% | 2.21% | 2.18% | 1.19% |
Profit Margin | 1.98% | 1.98% | 1.28% | 1.59% | 1.64% | 0.86% |
FCF Margin | 1.51% | 1.51% | 1.54% | 0.43% | -3.14% | 2.13% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 |
Dividend Per Share Dividend Per Share Growth | 0.600 | 0.600 | 0.500 | 0.400 | 0.250 |
Dividend Per Share Growth | 25.00% | 20.00% | 25.00% | 60.00% | - |
Dividend Yield | 0.55% | 0.80% | 0.43% | 0.65% | 0.45% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 10.36 | 7.11 | 19.47 | 10.91 | 10.71 | - |
P/FCF Ratio | 13.56 | 9.31 | 16.11 | 40.66 | - | - |
PS Ratio | 0.20 | 0.14 | 0.25 | 0.17 | 0.18 | - |